Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Q32 Bio Inc. (NASDAQ: QTTB)
QTTB Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
7.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-44.60%
QTTB Stock Analysis
QTTB
PE Ratio:
4.4
QTTB
PEG Ratio:
Not Available
QTTB
Forward EPS Growth (12 month):
0.00%
QTTB
PS Ratio:
2.9
QTTB
PSG Ratio:
Not Available
QTTB
Forward Revenue Growth (12 month):
0.00%
QTTB Articles
No data was found